Your browser doesn't support javascript.
loading
Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab.
Zhou, Cong; Clamp, Andrew; Backen, Alison; Berzuini, Carlo; Renehan, Andrew; Banks, Rosamonde E; Kaplan, Richard; Scherer, Stefan J; Kristensen, Gunnar B; Pujade-Lauraine, Eric; Dive, Caroline; Jayson, Gordon C.
Afiliación
  • Zhou C; Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Clamp A; Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Backen A; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Berzuini C; Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Renehan A; Clinical and Experimental Pharmacology Group, CRUK Manchester Institute, University of Manchester, Manchester, UK.
  • Banks RE; Centre for Biostatistics, University of Manchester, Manchester, UK.
  • Kaplan R; Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Scherer SJ; Clinical and Biomedical Proteomics Group, St James's University Hospital, Cancer Research UK Clinical Centre, University of Leeds, Leeds, UK.
  • Kristensen GB; MRC Clinical Trials Unit, University College London, London, UK.
  • Pujade-Lauraine E; Novartis/GSK Pharmaceutical Cooperation, East Hanover, NJ, USA.
  • Dive C; Department of Gynecological Oncology, Oslo University Hospital, Oslo, Norway.
  • Jayson GC; Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France.
Br J Cancer ; 115(2): 228-35, 2016 Jul 12.
Article en En | MEDLINE | ID: mdl-27351218
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Receptor TIE-2 / Proteínas Angiogénicas / Bevacizumab / Neovascularización Patológica Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Receptor TIE-2 / Proteínas Angiogénicas / Bevacizumab / Neovascularización Patológica Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido